Skip to main content

Paclitaxel/pexidartinib

Vanishing bile duct syndrome and drug-induced liver injury: case report

    Reactions Weekly volume 1815, page 266 (2020)Cite this article

    This is a preview of subscription content, access via your institution.

    Access options

    Buy single article

    Instant access to the full article PDF.

    USD 49.95

    Price excludes VAT (USA)
    Tax calculation will be finalised during checkout.

    Reference

    • Piawah S, et al. A case report of vanishing bile duct syndrome after exposure to pexidartinib (PLX3397) and paclitaxel. npj Breast Cancer 5: No. 1, 14 Jun 2019. Available from: URL: http://doi.org/10.1038/s41523-019-0112-z

    Download references

    Rights and permissions

    Reprints and Permissions

    About this article

    Verify currency and authenticity via CrossMark

    Cite this article

    Paclitaxel/pexidartinib. Reactions Weekly 1815, 266 (2020). https://doi.org/10.1007/s40278-020-81592-z

    Download citation

    • Published:

    • Issue Date:

    • DOI: https://doi.org/10.1007/s40278-020-81592-z